# CareDx Inc. (CDNA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $50.88, market value $2.6 billion.

## Valuation
- **P/E (trailing): 24.5×** (5-yr avg 23.0×, 3-yr avg 23.0×). CareDx Inc. trades at 24.5× trailing earnings, close to its own five-year average of 23.0×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 38.3×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 5.7×**. Each dollar of revenue is priced at 5.7×.
- **Price / book: 6.2×**. The shares trade at 6.2× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 20.9×**. Enterprise value is 20.9× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Earnings yield: 4.1%**. The inverse of the P/E: 4.1% of the price is earned each year.

## Profitability
- **Operating margin: 23.6%**. 23.6% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: -5.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -7.0%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 35.9%**. Return on all capital, debt included, is 35.9%: comfortably above what that capital costs.
- **Return on assets: 26.9%**. Each dollar of assets produces 26.9% of profit.

## Growth
- **Revenue growth (1 yr): 13.8%** (3-yr 5.7%/yr, 5-yr 14.6%/yr). Revenue grew 13.8% over the last year, against 14.6% a year compounded over five years.
- **EPS growth (1 yr): -143.0%**. Earnings per share fell 143.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. CareDx Inc. holds more cash than debt.
- **Current ratio: 2.86** (quick 2.86). Current assets cover the next year's liabilities 2.86 times.
- **Altman Z-score: 16.53**. A Z-score of 16.53 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. CareDx Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (6 analysts). 6 analysts cover CareDx Inc.; the consensus is buy, with an average price target of $52.33 (+3% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 288.4%** (YTD 170.1%, 3-mo 128.7%). The shares are up 288.4% over twelve months including dividends.
- **From 52-week high: -5.2%** (287.8% above the low). Trading 5% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 65**. An RSI of 65 is neutral.
- **Beta (1 yr): 1.37** (volatility 72%). Beta of 1.37 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CDNA · Page: https://foliofundamentals.com/stocks/cdna

Not investment advice.